Abstract
RESULTS: The response rate was 53% (107/201), and the median follow-up was 7 years (range 1.8-18.9). The respondents were 53% male, median age 72 years (median age at surgery was 66). Pathology included: 19 ampullary adenocarcinomas, 17 pancreatic adenocarcinomas, 15 cystadenomas, 17 IPMNs, 6 neuroendocrine tumors, 6 duodenal adenocarcinomas, 3 cholangiocarcinomas, and 24 other lesions. The majority lost weight (median -9.5kg), 46 required pancreatic enzymes, and 25 developed diabetes. Before surgery, 85% reported satisfaction with life, versus 94% after surgery. Of
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
